Clinical Applications

Contact us for help?

If you want to order or have more questions.

Contact us

Molecular technologies play an important role in evolving medicine. Monitoring genes and their activities can accurately reveal individual health and disease conditions. We develop and market predictive and personalized medicine products. Our technology core focuses on protecting and identifying genes in peripheral blood samples.

TheraLead™, a blood based molecular assay, is available via Clinicogen.

The coronavirus disease outbreak began in December 2019. It is spreading rapidly throughout the world, becoming pandemic.

GS™ COVID-19 Real-Time PCR Kit

The coronavirus disease outbreak began in December 2019. It is spreading rapidly throughout the world, becoming pandemic.
Better understanding of the disease and quickly identifying future treatment are in great need, such as the duration of the disease, pandemic surveillance, vaccine and drug development. GenoSensor has developed a highly sensitive assay that directly detects the viral genome (RNA) using real-time RT-PCR, thus efficiently helping you for your research needs.

  • All-in-one master mix for ease to use
  • Detection in a real-time, results within 1.2 hours
  • Quality, High Performance, Reliability

 

Cat #Product NameDescriptionSizePrice
2702-22
GS™ COVID-19 Real-Time PCR Kit - 30Provide all-in-one master mix including cDNA synthesis, PCR mix, primers and probe of each gene.
22
samples
Request a quote
2702-94
GS™ COVID-19 Real-Time PCR Kit - 126Provide all-in-one master mix including cDNA synthesis, PCR mix, primers and probe of each gene.
94
samples
Request a quote

 

For more up-to-date information on the current coronavirus outbreak, visit the WHO or CDC websites.

Contact us if you want to order for more questions. Please allow up to 48 hours for a response to your quote request.

• This test has not been FDA cleared or approved;

• This test has been authorized by FDA under an EUA for use by authorized laboratories;

• This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and,

• This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.